Viewing Study NCT00322556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-26 @ 10:03 PM
Study NCT ID: NCT00322556
Status: COMPLETED
Last Update Posted: 2012-10-26
First Post: 2006-05-05
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
Sponsor: CSL Behring
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Agammaglobulinemia View
None IgG Deficiency View
None Common Variable Immunodeficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunoglobulin Intravenous View
None Agammaglobulinemia View
None Hypogammaglobulinemia View
None Common variable immunodeficiency View
None Immunoglobulin G View
None Children View